巨噬细胞
骨关节炎
炎症
医学
免疫系统
先天免疫系统
免疫学
软骨
疾病
发病机制
治疗方法
生物信息学
滑膜关节
滑膜
临床试验
药物输送
软骨损伤
靶向给药
滑膜炎
蛋白水解酶
作者
Era Jain,Paul Nana Kwame Sagoe
摘要
Osteoarthritis (OA) is a highly prevalent, disabling, and painful disease of the joints, characterized by progressive cartilage degeneration, synovial fibrosis, and pain. Mounting evidence highlights synovial inflammation as a key driver of OA pathogenesis, underscoring its contributive role at all disease stages. Among immune cells, macrophages, central components of the innate immune system, play a pivotal role by releasing inflammatory mediators, growth factors, and proteolytic enzymes that drive joint damage. Traditionally, drug delivery strategies sought to avoid macrophage uptake; however, recent advances have shifted toward exploiting macrophages as therapeutic targets to modulate inflammation and promote tissue repair. Targeting macrophages and abating their associated inflammatory pathways offers the potential to slow OA progression. Despite this promise, our understanding of synovial macrophage biology remains limited, and therapeutic interventions have achieved only modest success. Selectively targeting macrophage subsets or specific signaling pathways may reduce systemic side effects and enhance therapeutic precision. This review summarizes current knowledge on macrophage involvement in OA pathogenesis and highlights emerging biomaterials and nanotechnology-based strategies for macrophage targeting and reprogramming. Finally, it underscores the need for robust preclinical models and well-designed clinical trials to translate macrophage-targeted therapies into effective disease-modifying treatments for OA.
科研通智能强力驱动
Strongly Powered by AbleSci AI